Cases 1 - 4 of 4
In re: Leatha Taylor, et al v. Bristol-Myers Squibb Company, et al
as 22-6078
Not Classified By Court:
In re: ONGLYZA (SAXAGLIPTIN) AND KOMBIGLYZE (SAXAGLIPTIN AND METFORMIN) PRODUCTS LIABILITY LITIGATION MDL 2809
Plaintiff / Appellant:
LEATHA TAYLOR, Individually and as Administratrix of Estate of David Taylor, KATHY BARNES, LISA ARLENE PEOPLES and others
Defendant / Appellee:
BRISTOL-MYERS SQUIBB COMPANY, ASTRAZENECA PHARMACEUTICALS LP, IPR PHARMACEUTICALS INC. and others
Royal v. Bristol-Myers Squibb Company et al
as 5:2018cv00256
Plaintiff:
Hubert Allen Royal
Defendant:
Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
Royal v. Bristol-Myers Squibb Company et al
as NCE/7:18-cv-00052
Plaintiff:
Hubert Allen Royal
Defendant:
Bristol - Myers Squibb Company , Astrazeneca Pharmaceuticals LP and McKesson Corporation
Royal v. Bristol-Myers Squibb Company et al
as 7:2018cv00052
Plaintiff:
Hubert Allen Royal
Defendant:
Bristol-Myers Squibb Company, Astrazeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
